Elliott Cohen, MD
Pulmonary Disease · Nashville, TNNPI 1497730501
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,150 of the $21,364 with a category attached, or 75.6%. Abiomed accounts for 94.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $12,262 and has fallen 97.6% since, to $290 in 2024.
Across 36 payments — averaging $593.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$20K
- Edwards Lifesciences$490
- Getinge USA Sales, LLC$225
- Abbott$152
- BD$151
- Vapotherm Inc$83
- plus $118 from 3 others
What the payments were for
- Speaking & faculty fees$16,15076%
- Travel & lodging$3,41316%
- Food & beverage$1,8018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 20 | $20,145 |
| Edwards Lifesciences | 5 | $490 |
| Getinge USA Sales, LLC | 3 | $225 |
| Abbott | 2 | $152 |
| BD | 1 | $151 |
| Vapotherm Inc | 2 | $83 |
| Nuwellis, Inc. | 1 | $50 |
| Ceribell, Inc. | 1 | $49 |
| Werfen USA LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$19,938
- HemoSphere$307
- 2ND GEN CENTRIMAG PRIMARY CONSOLE$130
- CARDIOHELP$108
How this compares
$21,364 in reported general payments places this provider in the 85th percentile of 339 pulmonary disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Nashville
- Lisa LancasterNashville$519K
- Otis RickmanNashville$392K
- Susan GarwoodNashville$343K
- Joao DeandradeNashville$245K
- Anna HemnesNashville$183K
- Bryan HayNashville$126K
- Karl KuhnNashville$106K
- Fabien MaldonadoNashville$83K
- Margaret SalisburyNashville$53K
- Victor KhaNashville$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.